Hieff™ T7 RNA Polymerase(low dsRNA, 1000 U/μL) _ 10636ES

YeasenSku: 10636ES50

Size: 50 KU
Prezzo:
Prezzo di vendita$765.00
Azione:
In magazzino

This product is a bacteriophage T7 RNA polymerase derived from recombinant expression in E. coli. It is a T7 RNA polymerase obtained by mutation after modification and optimization of wild-type T7, which can significantly reduce the dsRNA content. Double-stranded DNA containing the T7 promoter sequence is used as a template and NTP is used as a substrate to synthesize RNA complementary to the reverse single-stranded DNA downstream of the promoter. Double-stranded linear blunt-end or 5' protruding end DNA can be used as a substrate template for T7 RNA polymerase, so linear plasmids and PCR products can be used as templates for in vitro RNA synthesis.

Specifications

Source

Recombinant E. coli

Optimum temperature

37℃

Activity

1000 U/μL

Residual RNase

Negative

Storage buffer

50 mM Tris-HCl, 1 mM EDTA, 10 mM DTT, 100 mM NaCl, 0.1% Triton X-100, 50% (v/v) glycerol, pH7.9@25℃

Activity unit definition

The amount of enzyme required to incorporate 1 nmol of [3H] GMP into the acid-insoluble precipitate within 1 hour at 37℃ and pH8.0 is defined as one activity unit.

Components

Components No.

Name

10636ES50

(50 KU)

10636ES60

(500 KU)

10636ES72

(1 MU)

10636ES86

(10 MU)

10636

Hieff™ T7 RNA Polymerase (low dsRNA, 1000 U/μL)

50 μL

500 μL

1 mL

10 mL

Figures

1. Customer feedback 1

Experimental Design:

Parameter

Condition

Objective

To compare application performance between WT T7 and Low-dsRNA T7

Reaction Volume

20 µL

Template Length

2 kb

Test Samples

WT T7 & Low-dsRNA T7 RNA polymerase

Reaction Temperature

27 °C

Reaction Time

2 h

Results:

Table 1. Comparison of dsRNA Content and Yield Between WT T7 and Low-dsRNA T7

Enzyme Type

dsRNA Content (%)

Integrity (%)

Reaction Scale

WT T7

0.0030%

92.5

180 µg (20 µL)

Low-dsRNA T7

0.0003%

93.0

180 µg (20 µL)

Result Summary:

Low-dsRNA T7 reduced dsRNA content by approximately 10-fold while maintaining comparable RNA yield and integrity relative to WT T7.

2. Customer feedback 2

Table 2. Performance Comparison Under Different GAG Final Concentrations Yield (mg/mL)

GAG Final Concentration (mM)

Yield (mg/mL)

Integrity (%)

Capping Efficiency (%)

Transfection Efficiency (%)

WT

Yeasen

supplier A*

WT

Yeasen

supplier A*

WT

Yeasen

supplier A*

WT

Yeasen

supplier A*

10

12.14

11.376

12.103

88.1

92.5

92.3

96.7

100

100

44.60

33.63

30.76

5

11.82

10.716

11.337

82.2

91.1

91.5

98.3

100

100

42.30

32.78

32.37

2.5

11.31

10.716

11.066

82.9

91.7

91.8

98.8

97.3

97.8

39.78

31.68

32.59

1.5

11.98

—

—

78.9

—

—

97.7

—

—

—

—

—

1

11.75

—

—

80.0

—

—

90.5

—

—

—

—

—

0.5

11.65

—

—

80.9

—

—

70.1

—

—

—

—

—

Result Summary:

Effects of cap analog concentration on IVT performance. Reactions were carried out in a 20 µL system at 27 °C for 2 h using different T7 enzymes. RNA yield remained stable as cap analog input decreased, while integrity and capping efficiency showed a gradual decline. A cap analog concentration of ≥2.5 mM is recommended for optimal performance.

Storage

This product should be stored at -25~-15℃ for 1 year.

FAQ

Citations

Applications

Potrebbe piacerti anche

Indagine

FAQ

Il prodotto è solo per scopi di ricerca e non è destinato all'uso terapeutico o diagnostico su esseri umani o animali. Prodotti e contenuti sono protetti da brevetti, marchi e copyright di proprietà di Yeasen Biotechnology. I simboli dei marchi indicano il paese di origine, non necessariamente la registrazione in tutte le regioni.

Alcune applicazioni potrebbero richiedere ulteriori diritti di proprietà intellettuale di terze parti.

Yeasen è un sostenitore della scienza etica, convinto che la nostra ricerca debba affrontare questioni critiche garantendo al contempo sicurezza e standard etici.